AKT1 and acute lymphoblastic leukemia: We have shown that these B ALL cells increase phosphorylation of Akt upon stromal contact (Figure 2) and that treatment with idelalisib or GS-649443, both PI3Kδ inhibitors, inhibits this (Figure 3).